Brief: Venus Medtech Hangzhou Posts FY Loss Attributable Rmb373.6 Million
31/03/2022 16:27
March 31 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* FY LOSS ATTRIBUTABLE RMB373.6 MILLION VERSUS LOSS OF
RMB182
MILLION
* FY REVENUE RMB415.9 MILLION VERSUS RMB276 MILLION
Source text for Eikon: ID:nHKS3nypPv
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market